» Articles » PMID: 18444445

Relationship Between Fentanyl Dosage and Immune Function in the Postoperative Period

Overview
Journal J Opioid Manag
Date 2008 May 1
PMID 18444445
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anesthesia and surgery are associated with impairment of the immune system expressed as an excessive proinflammatory immune response and suppression of cell mediated immunity. Opioids, an integral part of anesthetic technique, possess an inhibitory effect on both humoral and cellular immune responses. It was the aim of the present study to examine the effect of various doses of fentanyl on cytokine production during the perioperative period.

Intervention: The effect of large (LDFA, 70-100 microg/kg), intermediate (IDFA, 23-30 microg/kg) and small (SDFA, 2-4 microg/kg) doses of fentanyl on the immune function in the postoperative period was investigated.

Participants: Sixty patients, randomly assigned to one of the three groups according to the dose of fentanyl were included in the study.

Methods: The ex vivo secretion of IL-1beta, IL-2, IL-6, and IL-10 and NK cell cytotoxicity (NKCC) of peripheral blood mononuclear cells (PBMC) was tested before, and at 24, 48, and 72 hours following surgery.

Results: The pattern of postoperative secretion of the proinflammatory cytokines IL-1beta and IL-6 and that of the anti-inflammatory cytokine IL-10 differed significantly between patients receiving SDFA and those receiving IDFA and LDFA, but was similar between the last two groups. A similar suppression of NKCC and IL-2 secretion was observed in the three groups.

Conclusions: The diminished proinflammatory cytokine response observed in patients treated by LDFA and IDFA suggests that although more stable immune function can be achieved by those methods in comparison with SDFA, it is recommendable to apply IDFA to avoid the side effects that might be observed using LDFA method.

Citing Articles

Association of postoperative opioid type with mortality and readmission rates: multicentre retrospective cohort study.

Winther S, Jimenez-Solem E, Sillesen M BJS Open. 2024; 8(6).

PMID: 39485888 PMC: 11529791. DOI: 10.1093/bjsopen/zrae113.


Pain Management in Animals with Oncological Disease: Opioids as Influencers of Immune and Tumor Cellular Balance.

Pinheiro A, Petrucci G, Dourado A, Silva F, Pires I Cancers (Basel). 2024; 16(17).

PMID: 39272873 PMC: 11394036. DOI: 10.3390/cancers16173015.


The impact of spinal anaesthesia on perioperative opioid consumption, postoperative pain and oncological outcome in radical retropubic prostatectomy-a retrospective before-and-after effectiveness study.

Funcke S, Schick-Bengardt X, Pinnschmidt H, Beyer B, Fischer M, Kahl U Perioper Med (Lond). 2022; 11(1):49.

PMID: 36184629 PMC: 9528149. DOI: 10.1186/s13741-022-00281-0.


Breast cancer recurrence and survival rates in patients who underwent breast-conserving surgery under non-mechanically ventilated anesthesia.

Kim R, Kawai A, Wakisaka M, Shimoyama M, Yasuda N, Kin T Cancer Rep (Hoboken). 2022; 6(1):e1643.

PMID: 35655440 PMC: 9875645. DOI: 10.1002/cnr2.1643.


The Influence of Analgesic Modalities on Postoperative Cancer Recurrence.

Edinoff A, Derise O, Sheppard A, Miriyala S, Virgen C, Kaye A Anesth Pain Med. 2022; 12(1):e123463.

PMID: 35433388 PMC: 8995873. DOI: 10.5812/aapm.123463.